Pharmacotherapy for Alcohol Use Disorder-Presentation

Video Transcription

Video Summary

In this video, Dr. Larissa Mooney, a Professor of Psychiatry at UCLA, presents on pharmacotherapy management for alcohol use disorder. She discusses the target audience and educational objectives, which include establishing a diagnosis for alcohol use disorder, explaining the rationale for using pharmacotherapy in treatment, and describing the dosing and mechanism of action for FDA-approved medications (naltrexone, acamprosate, and disulfiram) as well as off-label options (topiramate and gabapentin). Dr. Mooney emphasizes that medication should be used in combination with other treatment modalities, such as behavioral interventions and social support. She provides information on standard drink equivalents and drinking guidelines for men and women. The video also covers withdrawal management, including symptoms and treatment options. Dr. Mooney then presents a case vignette of a 52-year-old man with alcohol use disorder and discusses medication options for his specific situation. She highlights the importance of individualized treatment and the need to consider factors such as motivation for treatment, concurrent opioid use, and potential medication interactions. Dr. Mooney concludes by discussing the benefits and limitations of each medication and the role of behavioral treatments in conjunction with pharmacotherapy.

Asset Subtitle

View the recorded presentation to attest that you have viewed the presentation in its entirety.

Keywords

pharmacotherapy management

alcohol use disorder

FDA-approved medications

off-label options

withdrawal management

case vignette

individualized treatment

behavioral treatments